Correlation Between Alx Oncology and Structure Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alx Oncology and Structure Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alx Oncology and Structure Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alx Oncology Holdings and Structure Therapeutics American, you can compare the effects of market volatilities on Alx Oncology and Structure Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alx Oncology with a short position of Structure Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alx Oncology and Structure Therapeutics.

Diversification Opportunities for Alx Oncology and Structure Therapeutics

0.4
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Alx and Structure is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Alx Oncology Holdings and Structure Therapeutics America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Structure Therapeutics and Alx Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alx Oncology Holdings are associated (or correlated) with Structure Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Structure Therapeutics has no effect on the direction of Alx Oncology i.e., Alx Oncology and Structure Therapeutics go up and down completely randomly.

Pair Corralation between Alx Oncology and Structure Therapeutics

Given the investment horizon of 90 days Alx Oncology Holdings is expected to under-perform the Structure Therapeutics. In addition to that, Alx Oncology is 1.05 times more volatile than Structure Therapeutics American. It trades about -0.08 of its total potential returns per unit of risk. Structure Therapeutics American is currently generating about 0.0 per unit of volatility. If you would invest  5,569  in Structure Therapeutics American on August 26, 2024 and sell it today you would lose (2,228) from holding Structure Therapeutics American or give up 40.01% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Alx Oncology Holdings  vs.  Structure Therapeutics America

 Performance 
       Timeline  
Alx Oncology Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Alx Oncology Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Structure Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Structure Therapeutics American has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Alx Oncology and Structure Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alx Oncology and Structure Therapeutics

The main advantage of trading using opposite Alx Oncology and Structure Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alx Oncology position performs unexpectedly, Structure Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will offset losses from the drop in Structure Therapeutics' long position.
The idea behind Alx Oncology Holdings and Structure Therapeutics American pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world